InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Hurvitz Chaim, 董事. Officer active across 1 company, notably NRX Pharmaceuticals, Inc.. In total, 4 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €569k. History available since 16 November 2022. The latest transaction was disclosed on 30 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Chaim Hurvitz is a Director at NRX Pharmaceuticals, Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector allows him to make significant contributions to discussions on the company's direction. He is committed to supporting growth and innovation within NRX Pharmaceuticals.